---
title: "CERo Therapeutics Holdings, Inc. (CERO.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CERO.US.md"
symbol: "CERO.US"
name: "CERo Therapeutics Holdings, Inc."
industry: "Biotechnology"
---

# CERo Therapeutics Holdings, Inc. (CERO.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.cero.bio](https://www.cero.bio) |

## Company Profile

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid t...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.02 | 75/604 | - | - | - |
| PB | -0.09 | 458/604 | - | - | - |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-07T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 2 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.04 |

## References

- [Company Overview](https://longbridge.com/en/quote/CERO.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CERO.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CERO.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.